Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ 1 ) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative

The molecular pathology of Alzheimer's disease

Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708 · see citing works

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043 · see citing works

Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival

Hayashi, T., & Su, T.-P. (2007) · Cell · doi:10.1016/j.cell.2007.08.036 · Cited by 1,826 · see citing works

The pharmacology of sigma-1 receptors.

Maurice, T., & Su, T.-P. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.07.001 · Cited by 654 · see citing works

Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence

Fibiger, H. C. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90117-d · Cited by 599 · see citing works

Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction

Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 524 · see citing works

Muscarinic acetylcholine receptors: signal transduction through multiple effectors

Felder, C. C. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768353 · Cited by 508 · see citing works

The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit

Aydar, E., Palmer, C. P., Klyachko, V. A., & Jackson, M. B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00677-3 · Cited by 400 · see citing works

Regulating ankyrin dynamics: Roles of sigma-1 receptors

Hayashi, T., & Su, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.491 · Cited by 331 · see citing works

Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration.

HAYASHI, T., Maurice, T., & Su, T. (2000) · PubMed · Cited by 296 · see citing works

Sigma1 (σ1) receptor agonists and neurosteroids attenuate β25–35-amyloid peptide-induced amnesia in mice through a common mechanism

Maurice, T., Su, T., & Privat, A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00405-3 · Cited by 291 · see citing works

The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35peptide‐induced toxicity in mice involve an interaction with theσ1receptor

Meunier, J., Ieni, J. R., & Maurice, T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706927 · Cited by 289 · see citing works

Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia

Maurice, T., Hiramatsu, M., Itoh, J., Kameyama, T., Hasegawa, T., & Nabeshima, T. (1994) · Brain Research · doi:10.1016/0006-8993(94)91397-8 · Cited by 215 · see citing works

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

Kelly, J. F., Furukawa, K., Barger, S. W., Rengen, M., Mark, R. J., Blanc, E. M., Roth, G. S., & Mattson, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6753 · Cited by 209 · see citing works

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 191 · see citing works

The sigma‐1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus

Martina, M., B.‐Turcotte, M., Halman, S., & Bergeron, R. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.116178 · Cited by 187 · see citing works

The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test.

Urani, A., Roman, F. J., Phan, V. L., Su, T., & Maurice, T. (2001) · PubMed · Cited by 181 · see citing works

Neuroactive Neurosteroids as Endogenous Effectors for the Sigma1 (.SIGMA.1) Receptor. Pharmacological Evidence and Therapeutic Opportunities.

Maurice, T., Phan, V.-L., Urani, A., Kamei, H., Noda, Y., & Nabeshima, T. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.81.125 · Cited by 179 · see citing works

In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.

Monnet, F. P., Debonnel, G., & de Montigny, C. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10951-8 · Cited by 176 · see citing works

Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem.

Morin-Surun, M., Collin, T., Denavit-Saubié, M., Baulieu, E., & Monnet, F. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.14.8196 · Cited by 176 · see citing works

The Sigma1 Protein as a Target for the Non-genomic Effects of Neuro(active)steroids: Molecular, Physiological, and Behavioral Aspects

Monnet, F. P., & Maurice, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0050032 · Cited by 167 · see citing works

Ca2+ Signaling via ς1-Receptors: Novel Regulatory Mechanism Affecting Intracellular Ca2+Concentration

Hayashi, T., Maurice, T., & Su, T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39299-7 · Cited by 152 · see citing works

Galantamine prevents apoptosis induced by β-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors

Arias, E., Alés, E., Gabilan, N. H., Cano‐Abad, M. F., Villarroya, M., Garcı́a, A. G., & López, M. G. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00317-4 · Cited by 151 · see citing works

M1 Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy

Fisher, A., Pittel, Z., Haring, R., Bar-Ner, N., Kliger-Spatz, M., Natan, N., Egozi, I., Sonego, H., Marcovitch, I., & Brandeis, R. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:349 · Cited by 149 · see citing works

Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-Dependent Transcriptional Regulation of Nuclear Factor κB

Meunier, J., & Hayashi, T. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160960 · Cited by 148 · see citing works

Cholinergic-Mediated IP3-Receptor Activation Induces Long-Lasting Synaptic Enhancement in CA1 Pyramidal Neurons

de Sevilla, D. F., Núñez, Á., Borde, M., Malinow, R., & Buño, W. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2723-07.2008 · Cited by 143 · see citing works

Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.

Bymaster, F. P., Heath, I., Hendrix, J., et al. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39340-7 · Cited by 138 · see citing works

The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain

Emre, M., Geula, C., Ransil, B., & Mesulam, M. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90055-3 · Cited by 125 · see citing works

Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via σ1-receptors

Maurice, T., Junien, J., & Privat, A. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86061-5 · Cited by 124 · see citing works

Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity

Kihara, T., Sawada, H., Nakamizo, T., Kanki, R., Yamashita, H., Maelicke, A., & Shimohama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.132 · Cited by 124 · see citing works

Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity

Marrazzo, A., Caraci, F., Salinaro, E. T., Su, T., Copani, A., & Ronsisvalle, G. (2005) · Neuroreport · doi:10.1097/00001756-200508010-00018 · Cited by 120 · see citing works

Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice

Villard, V., Espallergues, J., Keller, E., Alkam, T., Nitta, A., Yamada, K., Nabeshima, T., Vamvakides, A., & Maurice, T. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.212 · Cited by 105 · see citing works

Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.

Matsuno, K., Matsunaga, K., Senda, T., & Mita, S. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38212-1 · Cited by 100 · see citing works

The Antidepressant-Like Effect Induced by ς1-Receptor Agonists and Neuroactive Steroids in Mice Submitted to the Forced Swimming Test

Urani, A., Roman, F. J., Phan, V., Su, T., & Maurice, T. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29502-1 · Cited by 100 · see citing works

TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons

Kato, K., Hayako, H., Ishihara, Y., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00943-4 · Cited by 94 · see citing works

Tacrine and donepezil attenuate the neurotoxic effect of Aβ(25-35) in rat PC12 cells

Svensson, A., & Nordberg, A. K. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00050 · Cited by 91 · see citing works

Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats

Quirion, R., Richard, J. W., & Wilson, A. L. (1994) · Synapse · doi:10.1002/syn.890170205 · Cited by 86 · see citing works

Memory deficits and increased emotionality induced by β-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus

Olariu, A., Tran, M. H., Yamada, K., Mizuno, M., Hefco, V., & Nabeshima, T. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170025 · Cited by 84 · see citing works

Therapeutic Strategies in Alzheimer’s Disease: Ml Muscarinic Agonists

Fisher, A. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.84.101 · Cited by 80 · see citing works

Interaction with σ1 Protein, but Not N-Methyl-d-aspartate Receptor, Is Involved in the Pharmacological Activity of Donepezil

Maurice, T., Meunier, J., Feng, B., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097394 · Cited by 80 · see citing works

Ameliorating effect of SA4503, a novel σ1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats

Senda, T., Matsuno, K., Okamoto, K., Kobayashi, T., Nakata, K., & Mita, S. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00572-9 · Cited by 79 · see citing works

SA4503, a novel cognitive enhancer, with σ1 receptor agonistic properties

Matsuno, K., Senda, T., Kobayashi, T., et al. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86074-3 · Cited by 75 · see citing works

Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats

Ohno, M., Yamamoto, T., & Watanabe, S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91790-6 · Cited by 70 · see citing works

High occupancy of σ1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503

Ishikawa, M., Sakata, M., Ishii, K., et al. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990204 · Cited by 68 · see citing works

Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis

Matsuno, K., Matsunaga, K., & Mita, S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90096-r · Cited by 50 · see citing works

Pregnancy reduces brain sigma receptor function

Bergeron, R., de Montigny, C., & Debonnel, G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702724 · Cited by 39 · see citing works

Reduction of the Scopolamine-Induced Impairment of Passive-Avoidance Performance by σ Receptor Agonist in Mice

Senda, T., Matsuno, K., Kobayashi, T., et al. (1997) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00447-7 · Cited by 35 · see citing works

Neurosteroid enhances glutamate release in rat prelimbic cortex via activation of α1-adrenergic and σ1 receptors

Dong, Y. W., Fu, Y., Sun, J., Zhu, Y. H., Sun, F., & Zheng, P. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5004-8 · Cited by 35 · see citing works

Neurotransmitter receptor plasticity in aging

Pedigo, N. W. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00378-5 · Cited by 34 · see citing works

Involvement of the sigma1(σ1) receptor in the anti‐amnesic, but not antidepressant‐like, effects of the aminotetrahydrofuran derivative ANAVEX1‐41

Espallergues, J., Lapalud, P., Christopoulos, A., Avlani, V. A., Sexton, P. M., Vamvakides, A., & Maurice, T. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707386 · Cited by 33 · see citing works

Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.

NAKAHARA, N., Iga, Y., Saito, Y., et al. (1989) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.51.539 · Cited by 29 · see citing works

Facilitation of memory storage by the acetylcholine M2 muscarinic receptor antagonist AF-DX 116

Baratti, C. M., Opezzo, J. W., & Kopf, S. R. (1993) · Behavioral and Neural Biology · doi:10.1016/0163-1047(93)90742-z · Cited by 27 · see citing works

Reactive oxygen species regulate signaling pathways induced by M1 muscarinic receptors in PC12M1 cells

Mangelus, M., Kroyter, A., Galron, R., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00162.x · Cited by 24 · see citing works

Amyloid β peptide 25–35 modulates hydrolysis of phosphoinositides by membrane phospholipase(s) C of adult brain cortex

Strosznajder, J. B., Zambrzycka, A., Kacprzak, M. D., & Strosznajder, R. P. (1999) · Journal of Molecular Neuroscience · doi:10.1007/bf02736924 · Cited by 24 · see citing works

Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia

Nakahara, N., Fujise, N., Kawanishi, G., et al. (1990) · Brain Research · doi:10.1016/0006-8993(90)90541-i · Cited by 22 · see citing works

Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer’s presenile dementia models

Malviya, M., Kumar, Y. C. S., Asha, D., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.06.053 · Cited by 19 · see citing works

Effects of cholinesterase inhibitors on learning and memory in rats: A brief review with special reference to THA

Mohammed, A. H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04247.x · Cited by 19 · see citing works

Changes in phosphoinositide signalling activity and levels of the alpha subunit of Gq/11 protein in rat brain induced by E-5842, a sigma1 receptor ligand and potential atypical antipsychotic

Romero, G., Pérez, M. P., Carceller, A., et al. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01353-7 · Cited by 12 · see citing works

[Mechanism of action of tetrahydro-N, N-dimethyl-5, 5-diphenyl-3-furanemethanamine, a putative nootropic, anti-epileptic and antidepressant compound].

Vamvakides, A. (2002) · PubMed · Cited by 10 · see citing works

[Anticonvulsant and forced swim anti-immobility effects of tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanemethanamine (AE37): common action mechanism?].

Vamvakides, A. (2002) · PubMed · Cited by 8 · see citing works

The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements.

Pal, A., Fontanilla, D., Gopalakrishnan, A., Chae, Y.-K., Markley, J. L., & Ruoho, A. E. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.030 · Cited by 177 · see citing works

From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology

Albertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179 · see citing works

Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies

Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813900 · Cited by 94 · see citing works

A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study

Hampel, H., Williams, C., Etcheto, A., Goodsaid, F., Parmentier, F., Sallantin, J., Kaufmann, W. E., Missling, C. U., & Afshar, M. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12013 · Cited by 84 · see citing works

ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome

Kaufmann, W. E., Sprouse, J., Rebowe, N., Hanania, T., Klamer, D., & Missling, C. U. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172796 · Cited by 54 · see citing works

Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo

Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00623 · Cited by 49 · see citing works

Sigma-1 receptor and seizures

Vavers, E., Zvejniece, L., & Dambrova, M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106771 · Cited by 30 · see citing works

Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy

Reyes, S. T., Deacon, R. M. J., Guo, S. G., Altimiras, F. J., Castillo, J. B., van der Wildt, B., Morales, A. P., Park, J. H., Klamer, D., Rosenberg, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94079-7 · Cited by 22 · see citing works

Mutational Analysis of Sigma-1 Receptor’s Role in Synaptic Stability

Ryskamp, D. A., Zhemkov, V., & Bezprozvanny, I. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01012 · Cited by 21 · see citing works

The muscarinic acetylcholine antagonist scopolamine impairs short-distance homing pigeon navigation

Kohler, E. C., Riters, L. V., Chaves, L. M., et al. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(96)00144-8 · Cited by 14 · see citing works

Alleviation of scopolamine amnesia by different retrieval enhancing treatments

Quartermain, D., & Leo, P. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90146-3 · Cited by 10 · see citing works

Cholinergic muscarinic binding by rat lymphocytes: Effects of antagonist treatment, strain and aging

Shenkman, L., Rabey, J. M., & Gilad, G. M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90226-x · Cited by 26 · see citing works

Biochemical indentification of the mammalian muscarinic cholinergic receptor.

Snyder, S. H., Chang, K. J., Kuhar, M. J., et al. (1975) · PubMed · Cited by 83 · see citing works

A Review on Medicinal Plants Affecting Amnesia on Scopolamine Induced Model

Prashar, Y., Gill, N. S., & Kakkar, S. (2014) · Pharmatutor · Cited by 2 · see citing works